Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:02 2024-07-17 EDT			5-day change	1st Jan Change
862.2 ^DKK	+0.09%		-1.03%	+11.68%

07-10	Danske Bank Upgrades Coloplast to Buy from Hold	MT
06-06	Transcript : Coloplast A/S - Analyst/Investor Day

Tranche Update on Coloplast A/S (CPSE:COLO B)'s Equity Buyback Plan announced on December 5, 2013.

January 29, 2015 at 05:49 am

From October 1, 2014 to December 4, 2014, the company has repurchased 0 shares, representing 0% for DKK 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for DKK 0 million under the buyback announced on December 5, 2013.

Latest news about Coloplast A/S

Danske Bank Upgrades Coloplast to Buy from Hold	07-10	MT
Transcript : Coloplast A/S - Analyst/Investor Day	06-06
COLOPLAST : Multiple silver linings in spite of a soft Q2 24	05-15
European shares hit one-month high as earnings take centre stage	05-07	RE
U.S. Futures Flat, European Stocks Rise	05-07	DJ
European shares hit one-month high on upbeat earnings, rate-cut optimism	05-07	RE
Transcript : Coloplast A/S, H1 2024 Earnings Call, May 07, 2024	05-07
Coloplast Posts Higher Fiscal H1 Net Profit, Revenue	05-07	MT
Coloplast Strengthens Ostomy Care Portfolio with Three Significant Product Launches	05-07	CI
Coloplast A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-07	CI
Coloplast A/S Revises Earnings Guidance for the Fiscal Year 2023/24	05-07	CI
Coloplast A/S Announces Interim Dividend for the First Half of 2023/24, Payable on May 15, 2024	05-07	CI
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.	02-26	CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat	02-14
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders	02-09	DJ
Global markets live: Tesco, Boeing, Roche, Exxon Mobil, PepsiCo...	02-09
Transcript : Coloplast A/S, Q1 2024 Earnings Call, Feb 09, 2024	02-09
European shares flat as higher yields counter earnings bump	02-09	RE
European shares inch up on earnings bump, higher yields weigh	02-09	RE
Coloplast Posts Growth in Fiscal Q1 Net Profit, Revenue	02-09	MT
Coloplast Launches Peristeen Light for People with Bowel Disorders	02-09	CI
Coloplast A/S Reports Earnings Results for the First Quarter Ended December 31, 2023	02-09	CI
Coloplast A/S Reaffirms Earnings Guidance for the Fiscal Year 2023/24	02-09	CI
Coloplast Rolls Out New Silicone Foam for Wound Care in US	01-31	MT
Coloplast A/SLaunches Biatain® Silicone Fit for Pressure Injury Prevention and Wound Management in the US	01-31	CI

Chart Coloplast A/S

Duration

Period

More charts

Company Profile

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-20 - Q3 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

COLOPLAST : Multiple silver linings in spite of a soft Q2 24

May 15, 2024 at 06:34 am

More Strategies

Ratings for Coloplast A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

861.4 DKK

Average target price

899.2 DKK

Spread / Average Target

+4.38%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
COLOPLAST A/S	+11.68%	28.25B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+28.34%	2.62B
HARTALEGA HOLDINGS	+28.15%	2.48B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-47.44%	2.31B
TOP GLOVE CORPORATION BHD.	+36.67%	2.07B
WINNER MEDICAL CO., LTD.	-31.46%	2.04B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-24.50%	1.61B
NAKANISHI INC.	+13.96%	1.43B
KOSSAN RUBBER INDUSTRIES	+36.22%	1.33B
GVS S.P.A.	+18.21%	1.27B

Medical Supplies